Live feed08:00:00·1282dPRReleasevia QuantisnowLigand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple MyelomaByQuantisnow·Wall Street's wire, on your screen.AHPA· Avista Public Acquisition Corp. IILGND· Ligand Pharmaceuticals IncorporatedHealth Care
